Riskpilot← Back to searchSign inGet full accessCURARE AS
ASActiveOrg 917763925Hieronymus Heyerdahls Gate 1, 0160 OsloBuying and selling of own real estate · NACE 6811Est. 20160 employees
Revenue 2024
NOK 19,6M
+95% vs 2023
EBITDA margin
98.5%
+97% vs 2023
Equity ratio
94.4%
Financial strength
Net profit 2024
NOK 17M
+97% vs 2023
| Revenue | NOK 19,6M | +95% |
| EBITDA | NOK 19,3M | +97% |
| Net profit | NOK 17M | +97% |
| Total assets | NOK 53,4M | -8% |
| Equity | NOK 50,5M | -1% |
| Employees | 0 | — |
Legal name
CURARE AS
Org number
917763925
Legal form
Aksjeselskap
NACE code
6811 · Buying and selling of own real estate
Founded
22. september 2016
Share capital
NOK 399 600
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Investere i verdipapirer og andre formuesobjekter, herunder deltagelse i andre selskaper med lignede virksomhet.
Address
Hieronymus Heyerdahls Gate 1, 0160 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 976 | 16 441 | 2 032 | 10 053 | 19 648 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 5 721 | 16 150 | 1 813 | 9 817 | 19 344 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 5 721 | 16 150 | 1 813 | 9 817 | 19 344 |
| Net financials | −37 | −41 | 1 867 | 158 | 582 |
| Profit before tax | 5 685 | 16 110 | 3 680 | 9 975 | 19 926 |
| Tax | −0 | 3 990 | 365 | 1 352 | 2 921 |
| Net profit | 5 685 | 12 120 | 3 315 | 8 622 | 17 005 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 67 592 | 71 447 | 59 653 | 58 202 | 53 443 |
| Equity | 53 960 | 55 963 | 57 373 | 51 005 | 50 476 |
| Long-term debt | 1 481 | 0 | 0 | 0 | 0 |
| Short-term debt | 12 151 | 15 484 | 2 281 | 7 197 | 2 967 |
| Total debt | 13 632 | 15 484 | 2 281 | 7 197 | 2 967 |
EBITDA margin
98.5%
This company
15.8%
Market median
+523% vs market
20202024
Equity ratio
94.4%
This company
38.2%
Market median
+147% vs market
20202024
Return on equity
33.7%
This company
18.4%
Market median
+83% vs market
20202024
Net profit margin
86.5%
This company
8.1%
Market median
+968% vs market
20202024
Asset turnover
0.37×
This company
1.12×
Market median
-67% vs market
20202024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MN Contact Person | Contact Person | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2016 | |
| Chairman | 2016 | |
| Board of Directors | 2016 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.78% | 33.78% | 2024 | |
| Company | 33.78% | 33.78% | 2024 | |
| Company | 13.51% | 13.51% | 2024 | |
| Company | 6.76% | 6.76% | 2024 | |
| Company | 6.76% | 6.76% | 2024 | |
| Company | 2.7% | 2.7% | 2024 | |
| Company | 1.35% | 1.35% | 2024 | |
| Company | 1.35% | 1.35% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Gaius As
CURARE AS Board members of CURARE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marianne Normann | Contact Person | 0 companies |
| Anders Gudmund Frøseth | Board of Directors | 0 companies |
| Marius Juul Møller | Chairman | 0 companies |
| Arne Medlien | Board of Directors | 0 companies |